-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- News & Events
- Releases & Announcements
Releases & Announcements
In the Spotlight
Researchers Show How a Tumor Cell’s Location and Environment Affect Its Identity
NCATS ∙ 06/23/2023 ∙ Division of Preclinical Innovation
Scientists created a system to pair the location of cells in a tumor with their gene activity. The work can help us understand how cancer grows and responds to treatments.
July 2023
-
NIH-Funded Study Explains Link to Increased Cardiovascular Risks for People With Obstructive Sleep Apnea
NHLBI, NCATS ∙ 07/26/2023 ∙ CTSA Program -
New Atlas of Human Kidney Cells to Help Unlock Kidney Disease Research
NIDDK, NCATS ∙ 07/19/2023 ∙ CTSA Program, RDCRN
June 2023
-
Researchers Show How a Tumor Cell’s Location and Environment Affect Its Identity
NCATS ∙ 06/23/2023 ∙ Division of Preclinical Innovation -
Screening Newborns for Deadly Immune Disease Saves Lives
NIAID ∙ 06/20/2023 ∙ RDCRN -
How Football Raises the Risk for Chronic Traumatic Encephalopathy
NINDS, NIA, NICHD, NCATS ∙ 06/20/2023 ∙ CTSA Program -
Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder
NIA, NCATS ∙ 06/13/2023 ∙ CTSA Program
May 2023
-
Obstructive Sleep Apnea Associated With Increased Risks for Long COVID
NHLBI, NCATS ∙ 05/11/2023 ∙ CTSA Program
March 2023
-
FDA-Approved Drug Shows Promise in Lab Models for Blinding Childhood Disease
NEI ∙ 03/29/2023 ∙ Division of Preclinical Innovation -
NIH Gene Therapy Team Reveals Its Path to FDA Orphan Drug and Rare Pediatric Disease Designations
NCATS ∙ 03/29/2023 ∙ Rare Diseases -
Tissue Chips in Space Projects Offer Glimpses Into the Biology of Aging
NCATS ∙ 03/23/2023 ∙ Tissue Chip for Drug Screening -
Data Science Tools Will Speed Rare Disease Solutions
National Library of Medicine ∙ 03/15/2023 ∙ Rare Diseases -
Scientists Reveal a Potential New Approach to Treating Liver Cancer
NCATS ∙ 03/13/2023 ∙ Division of Preclinical Innovation
February 2023
-
Forgoing One Food Treats Eosinophilic Esophagitis as Well as Excluding Six
NIAID ∙ 02/27/2023 ∙ RDCRN -
NIH RECOVER Research Identifies Potential Long COVID Disparities
NHLBI ∙ 02/16/2023 ∙ CTSA Program -
Lessons Learned From the NIH-Led Research Response to COVID-19
NIH ∙ 02/02/2023 ∙ NCATS
January 2023
-
New 3-D Model Offers Insights into the Role of Glucose in a Deadly Kidney Disease
NCATS ∙ 01/05/2023 ∙ Tissue Chip for Drug Screening
November 2022
-
NIH Names Dr. Joni L. Rutter Director of NCATS
NIH ∙ 11/08/2022 ∙ NCATS
October 2022
-
NIH-Supported Study Finds Racial Disparities in Advanced Heart Failure Treatment
NHLBI ∙ 10/19/2022 ∙ CTSA Program -
Tissue Chip Developments: What’s the 411?
NIBIB ∙ 10/04/2022 ∙ CTSA Program, Tissue Chip for Drug Screening
September 2022
-
Prenatal Steroid Treatment May Improve Survival, Reduce Complications for Extremely Preterm Infants
NICHD ∙ 09/26/2022 ∙ NCATS -
Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
NIDDK ∙ 09/21/2022 ∙ CTSA Program -
NIH-Funded Study Shows Sound Sleep Supports Immune Function
NHLBI ∙ 09/21/2022 ∙ CTSA Program -
Mount Sinai, NCATS Scientists Uncover a Potential New Path Against Neurological Disease
NCATS ∙ 09/08/2022 ∙ Division of Preclinical Innovation
- News & Media
- Funding & Notices
-